These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 26556733)

  • 1. Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion.
    Chen F; Dai Z; Kang Y; Lv G; Keller ET; Jiang Y
    Osteoporos Int; 2016 Apr; 27(4):1469-1476. PubMed ID: 26556733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial.
    Nagahama K; Kanayama M; Togawa D; Hashimoto T; Minami A
    J Neurosurg Spine; 2011 Apr; 14(4):500-7. PubMed ID: 21275549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study.
    Liang BC; Shi ZY; Wang B; Wu P; Kong LC; Yao JL; Li CW; Shi XL
    Orthop Surg; 2017 Feb; 9(1):103-109. PubMed ID: 28276638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of zoledronic acid on lumbar spinal fusion in osteoporotic patients.
    Ding Q; Chen J; Fan J; Li Q; Yin G; Yu L
    Eur Spine J; 2017 Nov; 26(11):2969-2977. PubMed ID: 28865035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
    Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
    J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of zoledronic acid on the volume of the fusion-mass in lumbar spinal fusion.
    Park YS; Kim HS; Baek SW; Kong DY; Ryu JA
    Clin Orthop Surg; 2013 Dec; 5(4):292-7. PubMed ID: 24340149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery.
    Li C; Wang HR; Li XL; Zhou XG; Dong J
    Acta Neurochir (Wien); 2012 Apr; 154(4):731-8. PubMed ID: 22297398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronic acid infusion for lumbar interbody fusion in osteoporosis.
    Tu CW; Huang KF; Hsu HT; Li HY; Yang SS; Chen YC
    J Surg Res; 2014 Nov; 192(1):112-6. PubMed ID: 24948545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Weekly Teriparatide Administration in Osseous Union Enhancement within Six Months After Posterior or Transforaminal Lumbar Interbody Fusion for Osteoporosis-Associated Lumbar Degenerative Disorders: A Multicenter, Prospective Randomized Study.
    Ebata S; Takahashi J; Hasegawa T; Mukaiyama K; Isogai Y; Ohba T; Shibata Y; Ojima T; Yamagata Z; Matsuyama Y; Haro H
    J Bone Joint Surg Am; 2017 Mar; 99(5):365-372. PubMed ID: 28244906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of zoledronic acid in an L6-L7 rabbit spine fusion model.
    Bransford R; Goergens E; Briody J; Amanat N; Cree A; Little D
    Eur Spine J; 2007 Apr; 16(4):557-62. PubMed ID: 16967298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+ breast cancer: the ProBONE II study.
    Hadji P; Kauka A; Ziller M; Birkholz K; Baier M; Muth M; Bauer M
    Osteoporos Int; 2014 Apr; 25(4):1369-78. PubMed ID: 24504100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study).
    Nakamura T; Fukunaga M; Nakano T; Kishimoto H; Ito M; Hagino H; Sone T; Taguchi A; Tanaka S; Ohashi M; Ota Y; Shiraki M
    Osteoporos Int; 2017 Jan; 28(1):389-398. PubMed ID: 27631091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate.
    Sambrook PN; Roux C; Devogelaer JP; Saag K; Lau CS; Reginster JY; Bucci-Rechtweg C; Su G; Reid DM
    Bone; 2012 Jan; 50(1):289-95. PubMed ID: 22061864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative bisphosphonate do not significantly alter the fusion rate after lumbar spinal fusion: a meta-analysis.
    Mei J; Song X; Guan X; Wu D; Wang J; Liu Q
    J Orthop Surg Res; 2021 Apr; 16(1):284. PubMed ID: 33926494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment.
    Anastasilakis AD; Polyzos SA; Makras P; Gkiomisi A; Savvides M; Papatheodorou A; Terpos E
    Osteoporos Int; 2013 Jul; 24(7):2127-32. PubMed ID: 23124716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
    Perifanis V; Vyzantiadis T; Tziomalos K; Vakalopoulou S; Garipidou V; Athanassiou-Metaxa M; Harsoulis F
    Ann Hematol; 2007 Jan; 86(1):23-30. PubMed ID: 17013645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fracture risk and zoledronic acid therapy in men with osteoporosis.
    Boonen S; Reginster JY; Kaufman JM; Lippuner K; Zanchetta J; Langdahl B; Rizzoli R; Lipschitz S; Dimai HP; Witvrouw R; Eriksen E; Brixen K; Russo L; Claessens F; Papanastasiou P; Antunez O; Su G; Bucci-Rechtweg C; Hruska J; Incera E; Vanderschueren D; Orwoll E
    N Engl J Med; 2012 Nov; 367(18):1714-23. PubMed ID: 23113482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab versus zoledronic acid in patients previously treated with zoledronic acid.
    Anastasilakis AD; Polyzos SA; Gkiomisi A; Saridakis ZG; Digkas D; Bisbinas I; Sakellariou GT; Papatheodorou A; Kokkoris P; Makras P
    Osteoporos Int; 2015 Oct; 26(10):2521-7. PubMed ID: 25990355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury.
    Bubbear JS; Gall A; Middleton FR; Ferguson-Pell M; Swaminathan R; Keen RW
    Osteoporos Int; 2011 Jan; 22(1):271-9. PubMed ID: 20358358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial.
    Crawford BA; Kam C; Pavlovic J; Byth K; Handelsman DJ; Angus PW; McCaughan GW
    Ann Intern Med; 2006 Feb; 144(4):239-48. PubMed ID: 16490909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.